Sherrington Robin, EVP, Strategy & Innovation at Xenon Pharmaceuticals Inc. (XENE), sold 29,116 shares at $30.23 ($889K) on 2022-03-04, disclosed to the SEC on 2022-03-08.
Open-market sale of $889k XENE by EVP, Strategy & Innovation. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.15 | 5,000 | $151K | 17.0% |
| 2 | $30.23 | 5,000 | $151K | 17.0% |
| 3 | $30.56 | 6,710 | $205K | 23.1% |
| 4 | $30.56 | 6,710 | $205K | 23.1% |
| 5 | $31.05 | 5,000 | $155K | 17.5% |
| 6 | $31.42 | 696 |
| $22K |
| 2.5% |
| Total | $30.54 avg | 29,116 | $889K | 100% |
| Filing → |
| XENE | SELL | 2021-06-01 | $228K | — | Filing → |